SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-007849
Filing Date
2017-02-09
Accepted
2017-02-09 16:45:52
Documents
4
Period of Report
2017-02-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-4037_18k.htm 8-K 24769
2 EX-3.1 a17-4037_1ex3d1.htm EX-3.1 148824
3 EX-99.1 a17-4037_1ex99d1.htm EX-99.1 276386
4 GRAPHIC g40371mmi001.jpg GRAPHIC 3064
  Complete submission text file 0001104659-17-007849.txt   455806
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 17588182
SIC: 2834 Pharmaceutical Preparations